Rhenman & Partners Asset Management AB
Top Portfolio Positions
86 positions ·
$810,489,947 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| BSX |
Boston Scientific Corp
Healthcare
|
625,000 | $39,218,750 | 4.84% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
48,100 | $37,163,984 | 4.59% | |
| LLY |
ELI LILLY & Co
Healthcare
|
33,715 | $31,010,045 | 3.83% | |
| INSM |
INSMED Inc
Healthcare
|
159,760 | $26,123,955 | 3.22% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
336,500 | $24,167,430 | 2.98% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
167,750 | $23,379,317 | 2.88% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
41,340 | $20,319,850 | 2.51% | |
| BIIB |
Biogen Inc.
Healthcare
|
109,100 | $20,001,303 | 2.47% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
43,485 | $19,417,791 | 2.40% | |
| ALHC |
Alignment Healthcare, Inc.
Healthcare
|
1,053,450 | $18,561,789 | 2.29% |
Portfolio Trend
25 quarters · across all stocks
Holdings in JAZZ
Shares Held
Position Value (USD)
25 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,347,004 | 75,890 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $12,585,100 | 74,030 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,524,954 | 95,030 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $11,570,263 | 109,030 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $15,431,845 | 124,300 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $17,918,325 | 145,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,361,130 | 93,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $12,167,220 | 114,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $17,669,106 | 146,729 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,206,982 | 123,634 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $18,591,984 | 143,634 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $17,975,650 | 145,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $21,949,500 | 150,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $20,391,680 | 128,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $17,527,635 | 131,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $24,961,600 | 160,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $28,328,203 | 181,976 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $36,946,000 | 290,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $36,458,800 | 280,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $39,080,800 | 220,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $41,092,500 | 250,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $36,311,000 | 220,000 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $24,240,300 | 170,000 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $15,120,110 | 137,032 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $11,968,800 | 120,000 | Shares | Sole | 2020-04-16 | |
| No 13F history on record for this holder in this stock. | ||||||